Sestrin2 reduces ferroptosis via the Keap1/Nrf2 signaling pathway after intestinal ischemia-reperfusion

Le-le Zhang,Ke Ding,Shi-shi Liao,Yi-guo Zhang,Hui-yang Liao,Rong Chen,Qing-tao Meng
DOI: https://doi.org/10.1016/j.freeradbiomed.2024.02.003
IF: 8.101
2024-02-07
Free Radical Biology and Medicine
Abstract:Sestrins are metabolic regulators that respond to stress by reducing the levels of reactive oxygen species (ROS) and inhibiting the activity of target of rapamycin complex 1 (mTORC1). Previous research has demonstrated that Sestrin2 mitigates ischemia-reperfusion (IR) injury in the heart, liver, and kidneys. However, its specific role in IIR injury remains unclear. To elucidate the role of Sestrin2 in intestinal ischemia-reperfusion injury, we conducted an experimental study using a C57BL/6J mouse model of IIR. We noticed an increase in the levels of Sestrin2 expression and indicators associated with ferroptosis. Our study revealed that manipulating Sestrin2 expression in Caco-2 cells through overexpression or knockdown resulted in a corresponding decrease or increase, respectively, in ferroptosis levels. Furthermore, our investigation revealed that Sestrin2 alleviated ferroptosis caused by IIR injury through the activation of the Keap1/Nrf2 signaling pathway. This finding highlights the potential of Sestrin2 as a therapeutic target for alleviating IIR injury. These findings indicated that the modulation of Sestrin2 could be a promising strategy for managing prolonged IIR injury.
biochemistry & molecular biology,endocrinology & metabolism
What problem does this paper attempt to address?